MISSION
"Editing the future by bringing together wisdom and ambition"

We search for solutions to social issues from the customer's perspective, and by bringing together the wisdom and aspirations of various organizations and people, we edit society and create an inspiring future.

NEWS

【画像表示位置の設定】を使用すると画像が正方形に表示されない可能性があります

INVESTMENT

Invests In Rhelixa, A Leading Epigenome Analysis Company




INVESTMENT

Invests In Sagri, A Company That Uses Satellite Data And AI Technology To Solve Agricultural Issues


INVESTMENT

Invests in Cykinso and forms a business alliance to accelerate the expansion of the Gut Microbiome business.


INVESTMENT

Invests in Euphoria, a provider of conditioning support software to a wide range of sports teams from middle and high school students to professional athletes.

COLLABORATION

Fast Beauty, and FANCL jointly implement "beauty" and "health" initiatives targeting a common customer base.


小見出し

ここをクリックして表示したいテキストを入力してください。テキストは「右寄せ」「中央寄せ」「左寄せ」といった整列方向、「太字」「斜体」「下線」「取り消し線」、「文字サイズ」「文字色」「文字の背景色」など細かく編集することができます。

ABOUT US

KIRIN HEALTH INNOVATION FUND

Fund
KIRIN-Global Brain Investment Limited Partnership
 
 
Fund Manager
Global Brain Corporation 
Investment Scope Start-up companies related to the health science field, both domestic and international
Investment Target
All Stage
Fund Size
Around 50 Million Japanese Yen 
Management Period
Ten years to 2020 
見出し ここをクリックして表示したいテキストを入力してください。テキストは「右寄せ」「中央寄せ」「左寄せ」といった整列方向、「太字」「斜体」「下線」「取り消し線」、「文字サイズ」「文字色」「文字の背景色」など細かく編集することができます。

Investment Policy 

Toward the realization of affluent lifestyles in which people can continue to be healthy in a very natural way,
We invest in and support startup companies with promising business models and technologies in the health science field,
both in Japan and overseas.

Investment Focus 
 

Technology leading to the evolution of the health sciences
Expansion of consumer touch points
Enhancement of customer experience in health awareness/behavior
Health data platform
小見出し
ここをクリックして表示したいテキストを入力してください。

PORTFOLIO

FAQ

実際の公開ページでは回答部分が閉じた状態で表示されます。

Investment Activities 

  • Investment Purpose 

    In order to realize Kirin's vision for its health science business, "to be a lifestyle partner in the age of 100 years of life," we are investing to strengthen existing businesses and create new businesses through partnerships with startup companies. We are willing to consider a wide range of investments and collaborations, regardless of the domain, to create value in the health science field.

  • Investment Stage

    We will consider a wide range of options regardless of stage.
  • Ticket Size

    Although we will make a decision on an individual case basis, the maximum amount per case is 500 million Japanese yen, and our track record is mainly investments ranging from tens to 100 million Japanese yen.
  • Target area

    We have a track record of investing in domestic and international startup companies.
  • Considering period

    The period varies depending on the project and a collaboration plan, but is a minimum of two months.
  • ここをクリックして表示したいテキストを入力してください。

    ここをクリックして表示したいテキストを入力してください。テキストは「右寄せ」「中央寄せ」「左寄せ」といった整列方向、「太字」「斜体」「下線」「取り消し線」、「文字サイズ」「文字色」「文字の背景色」など細かく編集することができます。

CONTACT US

Thank you for visiting our website.
If you are interested in KIRIN HEALTH INNOVATION FUND,
please contact us from the following link.